|
481 Pharmacists
expected to play key role in Ask About Medicines Week activities Pharmacists
will play a key role in the multidisciplinary approach to Ask About Medicines
Week (AAMW), according to one of the week's organisers ...more
481 New
report supports expanded pharmacist roles The public should “reap the benefits” of pharmacists redefining their roles, a Health Which? report has concluded
...more
482 Parents
need information about minor ailments and self-limiting conditions Many
parents are unsure to which health care professional they should turn
when their children are ill, a new survey has revealed ...more
482 Director
of self-care appointed at DoH A director for self-care issues
in England has been appointed by the Department of Health ...more
482 New
contract ballot papers go out New contract ballot papers are
to be sent to pharmacy contractors in England and Wales by the Pharmaceutical
Services Negotiating Committee next week ...more
482 MEP
welcomes opening of the new school of pharmacy in East Anglia The
new school of pharmacy at the University of East Anglia, which opened
last month, has been welcomed by Bashir Khanbhai, a pharmacist and MEP
for the East of England ...more
483 Revised
chemotherapy guidance must be implemented by end of November Updated
guidance on the administration of intrathecal chemotherapy has been issued
by the Department of Health ...more
483 Medicines
governance increases incident reporting Medication incident
reporting has increased ninefold in Northern Ireland's acute hospitals
since a pharmacy-based medicines governance team was established ...more
483 Correction
issued for BNF 46 relating to indinavir dosing The British
National Formulary has issued a correction to the 46th edition relating
to the dosing of indinavir ...more
483 Data
confidentiality review starts for yellow card reporting scheme A
wide ranging review of the confidentiality of data on adverse drug reactions
(ADRs) held by the Medicines and Healthcare products Regulatory Agency
has begun ...more
484 New
Boots boss spends time working in pharmacy Richard Baker,
the new chief executive of the Boots Co Plc, spent a day working in a
Boots The Chemists branch in Leicester last week ...more
484 Levocetirizine
offers no benefits according to French reviewers Levocetirizine
(Xyzal), the active enantiomer of cetirizine, is a commercial novelty
that offers no benefits for patients, according to a review ...more
484 Therapy
can stop after H pylori eradicated For patients with bleeding peptic ulcers that have healed following successful Helicobacter pylori eradication therapy, maintenance anti-ulcer treatment is not necessary to prevent ulcer recurrence, say Taiwanese researchers
...more
484 Topical
gentamicin corrects cystic fibrosis mutation Applying topical
gentamicin to the nasal epithelium of patients with cystic fibrosis can
correct one of the mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene that causes the disease ...more
484 Hepatitis
A offers asthma protection Exposure to hepatitis A virus (HAV)
may protect some people from asthma and other atopic diseases, according
to American researchers ...more
484 Imatinib
has bigger molecular effect Imatinib (Glivec) has a greater
effect on the main molecular abnormality of chronic myeloid leukaemia
(CML) than does interferon alfa plus cytarabine, new data show ...more
484 Anbesol
reclassification Seton Products Ltd has asked the Medicines
and Healthcare products Regulatory Agency to reclassify Anbesol Adult
Strength Gel as a general sale list medicine ...more
484 GSL application
for cetirizine syrup Galpharm has applied for its hayfever
and allergy relief syrup (citirizine hydrochloride 1mg/1ml) and tablets
(cetirizine hydrochloride 10mg) to be reclassified as
general sale list medicines ...more
485 Hormone replacement
treatments link with asthma and respiratory allergy Hormone
replacement therapy (HRT) appears to increase a woman's risk of developing
asthma or a respiratory allergy, according to research reported at the
13th annual congress of the European Respiratory Society in Vienna last
week ...more
485 Templates
issued for 18 PGDs for use in emergency care of patients Pharmacists
will be able to administer a range of medicines, including adrenaline,
emergency hormonal contraception and glucagon, under patient group directions
(PGDs) for emergency care issued by the Department of Health this week
...more
485 First male
cancer centre The United Kingdom's first male cancer centre
has opened at the Western General Hospital, Edinburgh ...more
485 Portable
oxygen on the NHS Community pharmacies in Scotland will be
able to supply portable oxygen cylinders on the National Health Service
from April next year ...more
485 New primary
care funding Additional funding for primary care services
in Scotland was announced last week ...more |
Research & development
487 Strains
identified for cervical cancer human papillomavirus vaccine Researchers
have identified strains of human papillomavirus (HPV) that could be used
to prevent up to 84 per cent of cervical cancer cases, participants at
the recent European Cancer Conference in Copenhagen heard ...more
487 Hope
for pancreatic cancer vaccine Early trial results for a pancreatic
cancer vaccine used as treatment have raised hope for the development
of this therapy ...more
487 Pro-drug
improves lung function Asthma patients attain greater improvements
in lung function with ciclesonide, a new inhaled corticosteroid pro-drug,
than with budesonide, results from a 12-week trial have shown ...more
487 Cannabis
reduces sleep disturbance The cannabis extract mouth spray,
Sativex, reduces both neuropathic pain and sleep disturbance in patients
with multiple sclerosis compared with placebo, according to recent data
...more
488 Promising
male hormone contraceptive Results of an Australian study
of a male hormonal contraceptive tested in 55 couples report no pregnancies
over 12 months ...more
488 Depression
relapse rate decreases with new dual re-uptake inhibitor Patients
with major depressive disorder taking duloxetine hydrochloride, a serotonin
and norepinephrine re-uptake inhibitor, have a lower risk of relapse
compared with patients on placebo, findings presented at the annual congress
of the European College of Neuropsychopharmacology in Prague last month
indicate ...more
488 New
class of anxiolytics The anxiolytic effect of pregabalin,
a novel agent that also demonstrates efficacy for epilepsy and neuropathic
pain, is apparent after one week according to a poster presented at the
annual congress of the European College of Neuropsychopharmacology in
Prague ...more
488 Alzheimer's
vaccine hope Although a phase II multi-centre trial of a vaccine
for Alzheimer's disease was suspended last year, because of cases of
aseptic meningoencephalitis in 6 per cent of participants, an independent
follow-up study of a cohort (n=30) in Zurich has found that the vaccine
did slow disease progression in 20 cases ...more
488 GABA-A
agonist in trial for insomnia Gaboxadol, a gamma-aminobutyric
acid type A receptor agonist has entered a phase III clinical trial for
treating insomnia ...more
488 Anxiety
now target for new drug Aprepitant, the substance P receptor
antagonist approved by the United States Food and Drug Administration
in March 2003 for treating chemotherapy induced nausea and vomiting,
is in phase III trials as a treatment for anxiety ...more |
